Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
166 hedge funds and large institutions have $437M invested in Avid Bioservices, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 52 reducing their positions, and 33 closing their positions.
120% more call options, than puts
Call options by funds: $2.65M | Put options by funds: $1.21M
17% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 52
15% more capital invested
Capital invested by funds: $381M → $437M (+$55.8M)
5% less funds holding
Funds holding: 174 → 166 (-8)
24% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
+$18.9M |
| 2 |
NM
Newtyn Management
New York
|
+$10.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.56M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.66M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$28.3M |
| 2 |
Morgan Stanley
New York
|
-$5.16M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$3.17M |
| 4 |
HF
HRT Financial
New York
|
-$2.88M |
| 5 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.4M |
CDMO Hedge Fund Activity: Q1 2024 in Review
166 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2024, worth a combined $437M — up 15% from $381M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of CDMO and 25 opened new positions — a net loss of 8 holders — while 52 trimmed existing stakes and 61 added.
The largest buyer was 12 West Capital Management, opening a new position worth an estimated $18.9M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $28.3M sold.
- 166 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2024, down from 174 in Q4 2023.
- Funds reported $437M of Avid Bioservices, Inc. Common Stock stock for Q1 2024, up 15% quarter-over-quarter.
- 25 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2024 and 33 closed out, a net change of -8 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2024 was 12 West Capital Management, an estimated $18.9M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $28.3M sold.
Based on aggregated 13F filings for Q1 2024.